Literature DB >> 15525241

Australian women's perceptions of a specialist breast nurse model.

Barbara Liebert1, Susan Furber.   

Abstract

The aim of this study was to evaluate Australian women's perceptions of the specialist breast nurse (SBN) model developed by the National Breast Cancer Centre. Two hundred and forty women evaluated the care they received from a SBN. The SBN was perceived as a valuable link between women and the multi-disciplinary team, with continuity of care being rated as a major benefit. Over 80% of women reported the SBN to be effective in providing information and emotional support. There is a need to consider the establishment of SBN positions in treatment centres for breast cancer in Australia.

Entities:  

Mesh:

Year:  2004        PMID: 15525241     DOI: 10.1071/ah042720088

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  5 in total

Review 1.  What do consumers see as important in the continuity of their care?

Authors:  Megan Barnet; Tim Shaw
Journal:  Support Care Cancer       Date:  2013-07-05       Impact factor: 3.603

2.  A qualitative exploration of oncology nurses' family assessment practices in Denmark and Australia.

Authors:  Elisabeth Coyne; Karin B Dieperink
Journal:  Support Care Cancer       Date:  2016-10-10       Impact factor: 3.603

Review 3.  Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes.

Authors:  J Shao; M Rodrigues; A L Corter; N N Baxter
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

4.  The Various Roles of Oncology Nurse Specialists: An International Perspective.

Authors:  Ilana Kadmon
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Apr-Jun

5.  Potential inequities in availability of care from breast care nurses: a qualitative study reporting the experiences and perspectives of women with metastatic breast cancer in Australia.

Authors:  Andrea L Smith; Frances Boyle; Sophie Lewis
Journal:  BMC Health Serv Res       Date:  2022-07-22       Impact factor: 2.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.